Chemokine receptor binding compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 405/06 (2006.01) C07D 405/12 (2006.01) C07D 413/06 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2548393

The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).

L'invention concerne des composés de liaison aux récepteurs de la chemokine, des compositions pharmaceutiques et leur utilisation. L'invention concerne, plus spécifiquement, des modulateurs de l'activité des récepteurs de la chemokine, de préférence, des modulateurs de CCR5. Lesdits composés possèdent des effets protecteurs contre une infection de cellules cibles par le virus de l'immunodéficience humaine (VIH).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chemokine receptor binding compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine receptor binding compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor binding compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1384274

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.